458 related articles for article (PubMed ID: 22588087)
1. Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.
Zomer E; Liew D; Owen A; Magliano DJ; Ademi Z; Reid CM
Eur J Prev Cardiol; 2014 Mar; 21(3):384-90. PubMed ID: 22588087
[TBL] [Abstract][Full Text] [Related]
2. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
Chen L; Tonkin AM; Moon L; Mitchell P; Dobson A; Giles G; Hobbs M; Phillips PJ; Shaw JE; Simmons D; Simons LA; Fitzgerald AP; De Backer G; De Bacquer D
Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):562-70. PubMed ID: 19741542
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of different definitions of metabolic syndrome in predicting cardiovascular events in a cohort of non-diabetic Tehranian adults.
Hosseinpanah F; Asghari G; Barzin M; Golkashani HA; Azizi F
Int J Cardiol; 2013 Sep; 168(1):369-74. PubMed ID: 23041003
[TBL] [Abstract][Full Text] [Related]
4. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
Metcalf PA; Wells S; Scragg RK; Jackson R
N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
[TBL] [Abstract][Full Text] [Related]
5. Comparative performance of diabetes-specific and general population-based cardiovascular risk assessment models in people with diabetes mellitus.
Echouffo-Tcheugui JB; Kengne AP
Diabetes Metab; 2013 Oct; 39(5):389-96. PubMed ID: 24080092
[TBL] [Abstract][Full Text] [Related]
6. Assessing 10-Year Cardiovascular Disease Risk in Malaysians With Type 2 Diabetes Mellitus: Framingham Cardiovascular Versus United Kingdom Prospective Diabetes Study Equations.
Yew SQ; Chia YC; Theodorakis M
Asia Pac J Public Health; 2019 Oct; 31(7):622-632. PubMed ID: 31535566
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular risk factors (diabetes, hypertension, hypercholesterolemia and metabolic syndrome) in older people with intellectual disability: results of the HA-ID study.
de Winter CF; Bastiaanse LP; Hilgenkamp TI; Evenhuis HM; Echteld MA
Res Dev Disabil; 2012; 33(6):1722-31. PubMed ID: 22699246
[TBL] [Abstract][Full Text] [Related]
8. Validation of two Framingham cardiovascular risk prediction algorithms in an Australian population: the 'old' versus the 'new' Framingham equation.
Zomer E; Owen A; Magliano DJ; Liew D; Reid C
Eur J Cardiovasc Prev Rehabil; 2011 Feb; 18(1):115-20. PubMed ID: 20473180
[TBL] [Abstract][Full Text] [Related]
9. Continuous metabolic syndrome risk score for predicting cardiovascular disease in the Chinese population.
Kang GD; Guo L; Guo ZR; Hu XS; Wu M; Yang HT
Asia Pac J Clin Nutr; 2012; 21(1):88-96. PubMed ID: 22374565
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study.
Guzder RN; Gatling W; Mullee MA; Mehta RL; Byrne CD
Diabet Med; 2005 May; 22(5):554-62. PubMed ID: 15842509
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.
Jurado J; Ybarra J; Solanas P; Caula J; Gich I; Pou JM; Romeo JH
J Am Acad Nurse Pract; 2009 Mar; 21(3):140-8. PubMed ID: 19302689
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of metabolic syndrome and prediction of diabetes using IDF versus ATPIII criteria in a Middle East population.
Hajat C; Shather Z
Diabetes Res Clin Pract; 2012 Dec; 98(3):481-6. PubMed ID: 23140808
[TBL] [Abstract][Full Text] [Related]
13. Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis.
Athyros VG; Elisaf MS; Alexandrides T; Achimastos A; Ganotakis E; Bilianou E; Karagiannis A; Liberopoulos EN; Tziomalos K; Mikhailidis DP;
Angiology; 2012 Jul; 63(5):358-66. PubMed ID: 22007026
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus.
Wannamethee SG; Shaper AG; Lennon L; Morris RW
Arch Intern Med; 2005 Dec 12-26; 165(22):2644-50. PubMed ID: 16344423
[TBL] [Abstract][Full Text] [Related]
15. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
[TBL] [Abstract][Full Text] [Related]
16. Predictive accuracy of the 'Framingham's general CVD algorithm' in a Middle Eastern population: Tehran Lipid and Glucose Study.
Bozorgmanesh M; Hadaegh F; Azizi F
Int J Clin Pract; 2011 Mar; 65(3):264-73. PubMed ID: 21314863
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study.
Rutter MK; Meigs JB; Sullivan LM; D'Agostino RB; Wilson PW
Circulation; 2004 Jul; 110(4):380-5. PubMed ID: 15262834
[TBL] [Abstract][Full Text] [Related]
18. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.
Riddell T; Wells S; Jackson R; Lee AW; Crengle S; Bramley D; Ameratunga S; Pylypchuk R; Broad J; Marshall R; Kerr A
N Z Med J; 2010 Feb; 123(1309):50-61. PubMed ID: 20186242
[TBL] [Abstract][Full Text] [Related]
19. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
[TBL] [Abstract][Full Text] [Related]
20. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
